Biography of Karim Dabbagh
Last update: November 13, 2023Career
Karim was Vice President and Head of the Immunoregulation, External R&D Innovation, Autoimmune and Inflammatory Diseases for Pfizer. Karim Dabbagh joined Second Genome in 2014. Karim served as Chief Scientific Officer at Second Genome.
Karim Dabbagh is currently- President, Chief Executive Officer and Director at Second Genome - View - Second Genome org chart
- Chairman of the Board at MaaT Pharma - View - MaaT Pharma org chart
Create your alert
to follow the career of Karim Dabbagh.
Education
Karim Dabbagh has a Postdoctoral Fellowship from Cardiovascular Research Institute at the University of California.
More about Karim Dabbagh
Selected links
Do you need to know more about Karim Dabbagh? More results.
Participate
Social media
- Karim Dabbagh on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Karim Dabbagh
The colleagues of Karim Dabbagh
Company Colleagues
- At Second Genome, Karim Dabbagh has 8 colleagues including Corey Goodman (Chairman of the Board), Jason Lettmann (Director)…
- At MaaT Pharma, Karim Dabbagh has 12 colleagues including Hervé Affagard (CEO), Dorothée Burkel (Director)…
Industry Colleagues
- In the Biotechnology industry, Karim Dabbagh has 30,251 colleagues in 2,282 companies located in 40 countries. 14,430 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Karim Dabbagh.
Get in Touch
and ask for Karim Dabbagh.
